Literature DB >> 19029091

Bone morphogenic protein 2 activates protein kinase D to regulate histone deacetylase 7 localization and repression of Runx2.

Eric D Jensen1, Rajaram Gopalakrishnan, Jennifer J Westendorf.   

Abstract

The transcriptional activity of Runx2 is determined by associations with co-repressors including histone deacetylase 7 (HDAC7). We previously found that bone morphogenic protein 2 (BMP2) induces export of HDAC7 from the nucleus. In this study we demonstrate that BMP2 specifically stimulates redistribution of HDAC7 but not HDAC 4, 5, or 6. HDAC7 subcellular redistribution in mesenchymal cells requires Crm1-mediated nuclear export, is associated with increased HDAC7 serine phosphorylation, and requires conserved serines in the HDAC7 amino terminus. The protein kinase D (PKD) inhibitor Gö6976 blocked both basal and BMP2-directed HDAC7 nuclear export. Protein kinase D1 (PKD1) associated with HDAC7 in a BMP2-enhanced manner, and a constitutively active form of PKD1 stimulated HDAC7 nuclear export. Furthermore, active PKD1 inhibited repression of Runx2-mediated transcription by HDAC7. Suppression of HDAC7 was not sufficient to rescue BMP2 induction of osteoblast marker genes in Gö6976-treated cells, indicating that PKD-dependent factors beyond attenuation of HDAC7-repressive activity are required for osteoblast differentiation. These results establish a novel pathway by which BMP signaling regulates Runx2 activity via PKD-dependent inhibition of HDAC7 transcriptional repression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19029091      PMCID: PMC2629084          DOI: 10.1074/jbc.M800586200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

Review 1.  Histone deacetylase co-repressor complex control of Runx2 and bone formation.

Authors:  Eric D Jensen; Aswathy K Nair; Jennifer J Westendorf
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2007       Impact factor: 1.807

2.  Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10.

Authors:  Shurong Chang; Bryan D Young; Shijie Li; Xiaoxia Qi; James A Richardson; Eric N Olson
Journal:  Cell       Date:  2006-07-28       Impact factor: 41.582

3.  A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.

Authors:  Eileen M Shore; Meiqi Xu; George J Feldman; David A Fenstermacher; Tae-Joon Cho; In Ho Choi; J Michael Connor; Patricia Delai; David L Glaser; Martine LeMerrer; Rolf Morhart; John G Rogers; Roger Smith; James T Triffitt; J Andoni Urtizberea; Michael Zasloff; Matthew A Brown; Frederick S Kaplan
Journal:  Nat Genet       Date:  2006-04-23       Impact factor: 38.330

4.  Regulation of cardiac stress signaling by protein kinase d1.

Authors:  Brooke C Harrison; Mi-Sung Kim; Eva van Rooij; Craig F Plato; Philip J Papst; Rick B Vega; John A McAnally; James A Richardson; Rhonda Bassel-Duby; Eric N Olson; Timothy A McKinsey
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

Review 5.  Networks and hubs for the transcriptional control of osteoblastogenesis.

Authors:  Jane B Lian; Gary S Stein; Amjad Javed; Andre J van Wijnen; Janet L Stein; Martin Montecino; Mohammad Q Hassan; Tripti Gaur; Christopher J Lengner; Daniel W Young
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 6.514

6.  Shuttling of HDAC5 in H9C2 cells regulates YY1 function through CaMKIV/PKD and PP2A.

Authors:  Carmen C Sucharov; Stephen Langer; Michael Bristow; Leslie Leinwand
Journal:  Am J Physiol Cell Physiol       Date:  2006-07-05       Impact factor: 4.249

Review 7.  Transcriptional co-repressors of Runx2.

Authors:  Jennifer J Westendorf
Journal:  J Cell Biochem       Date:  2006-05-01       Impact factor: 4.429

8.  Bone morphogenetic protein-2 stimulates Runx2 acetylation.

Authors:  Eun-Joo Jeon; Kwang-Youl Lee; Nam-Sook Choi; Mi-Hye Lee; Hyun-Nam Kim; Yun-Hye Jin; Hyun-Mo Ryoo; Je-Yong Choi; Minoru Yoshida; Norikazu Nishino; Byung-Chul Oh; Kyeong-Sook Lee; Yong Hee Lee; Suk-Chul Bae
Journal:  J Biol Chem       Date:  2006-04-13       Impact factor: 5.157

9.  Protein kinase D directly phosphorylates histone deacetylase 5 via a random sequential kinetic mechanism.

Authors:  Q Khai Huynh; Timothy A McKinsey
Journal:  Arch Biochem Biophys       Date:  2006-03-09       Impact factor: 4.013

Review 10.  Bone morphogenetic proteins in clinical applications.

Authors:  Oliver P Gautschi; Sönke P Frey; René Zellweger
Journal:  ANZ J Surg       Date:  2007-08       Impact factor: 1.872

View more
  32 in total

Review 1.  Hdac-mediated control of endochondral and intramembranous ossification.

Authors:  Elizabeth W Bradley; Meghan E McGee-Lawrence; Jennifer J Westendorf
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

Review 2.  Histone deacetylases in skeletal development and bone mass maintenance.

Authors:  Meghan E McGee-Lawrence; Jennifer J Westendorf
Journal:  Gene       Date:  2010-12-22       Impact factor: 3.688

Review 3.  Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease.

Authors:  Jonathan A R Gordon; Janet L Stein; Jennifer J Westendorf; Andre J van Wijnen
Journal:  Bone       Date:  2015-03-31       Impact factor: 4.398

4.  Protein kinase D promotes in vitro osteoclast differentiation and fusion.

Authors:  Kim C Mansky; Eric D Jensen; Julia Davidova; Masato Yamamoto; Rajaram Gopalakrishnan
Journal:  J Biol Chem       Date:  2013-02-21       Impact factor: 5.157

Review 5.  Protein kinase D: coupling extracellular stimuli to the regulation of cell physiology.

Authors:  Ya Fu; Charles S Rubin
Journal:  EMBO Rep       Date:  2011-07-08       Impact factor: 8.807

6.  Runx2 trans-activation mediated by the MSX2-interacting nuclear target requires homeodomain interacting protein kinase-3.

Authors:  Oscar L Sierra; Dwight A Towler
Journal:  Mol Endocrinol       Date:  2010-05-19

7.  Deletion of protein kinase D1 in osteoprogenitor cells results in decreased osteogenesis in vitro and reduced bone mineral density in vivo.

Authors:  Wendy B Bollag; Vivek Choudhary; Qing Zhong; Ke-Hong Ding; Jianrui Xu; Ranya Elsayed; Kanglun Yu; Yun Su; Lakiea J Bailey; Xing-Ming Shi; Mohammed Elsalanty; Maribeth H Johnson; Meghan E McGee-Lawrence; Carlos M Isales
Journal:  Mol Cell Endocrinol       Date:  2017-08-12       Impact factor: 4.102

8.  PTH Signaling and Epigenetic Control of Bone Remodeling.

Authors:  Florante Ricarte; Teruyo Nakatani; Nicola Partridge
Journal:  Curr Mol Biol Rep       Date:  2016-02-03

9.  A positive role of microRNA-15b on regulation of osteoblast differentiation.

Authors:  S Vimalraj; Nicola C Partridge; N Selvamurugan
Journal:  J Cell Physiol       Date:  2014-09       Impact factor: 6.384

Review 10.  Regulation of gene expression in osteoblasts.

Authors:  Eric D Jensen; Rajaram Gopalakrishnan; Jennifer J Westendorf
Journal:  Biofactors       Date:  2010 Jan-Feb       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.